Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases

The survival benefit of anti–vascular endothelial growth factor (VEGF) therapy in metastatic colorectal cancer (mCRC) patients is limited to a few months because of acquired resistance. We show that anti-VEGF therapy induced remodeling of the extracellular matrix with subsequent alteration of the ph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Transl Med
Autors principals: Rahbari, Nuh N., Kedrin, Dmitriy, Incio, Joao, Liu, Hao, Ho, William W., Nia, Hadi T., Edrich, Christina M., Jung, Keehoon, Daubriac, Julien, Chen, Ivy, Heishi, Takahiro, Martin, John D., Huang, Yuhui, Maimon, Nir, Reissfelder, Christoph, Weitz, Jurgen, Boucher, Yves, Clark, Jeffrey W., Grodzinsky, Alan J., Duda, Dan G., Jain, Rakesh K., Fukumura, Dai
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5457741/
https://ncbi.nlm.nih.gov/pubmed/27733559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaf5219
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars